Abstract
(Abstracted from Aust N Z J Obstet Gynaecol 2021;61:347–353) Previous studies have reported that aspirin can be used to reduce the prevalence of both early-onset preeclampsia (ePET) and fetal growth restriction (FGR). The prevention of FGR would improve both pregnancy and infant outcomes and could also reduce costs to the health care system.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.